Skip to content

Clinical trials

Completed Urinary Bladder Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Status: Completed Country / region: Japan Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20154
20163
20171
20183
20191
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Hoffmann-La Roche2
Merck Sharp & Dohme LLC2
Pfizer2
Astellas Pharma Global Development, Inc.1
Astellas Pharma Inc1
Bayer1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Cedars-Sinai Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms16
Carcinoma, Transitional Cell6
Ureteral Neoplasms3
Urethral Neoplasms3
Biliary Tract Neoplasms2
Carcinoma, Hepatocellular2
Carcinoma, Non-Small-Cell Lung2
Lung Neoplasms2
Squamous Cell Carcinoma of Head and Neck2
Stomach Neoplasms2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.